week 7 semaglutide Once-weekly 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial Semaglutide results week by week:

Today we announced positive topline results from the first Phase 1b clinical trial of elecoglipron conducted in China in adults living with obesity/overweight, with or without type 2 diabetes

He discusses the good and the bad parts of this medication.

Women benefit most when we treat menopause as the metabolic inflection point it isnot just prescribing GLP-1s in isolation, but considering hormone therapy, addressing sleep disruption (which drives cortisol and undermines any weight loss effort), and building strength to counter the lean mass loss these medications can cause

biotech firms are testing GLP-1 weight-loss treatments for overweight cats as pet health spending grows and demand for new obesity solutions rises.

Revitalizes scalp for thicker hair

Peel off the backing and apply to clean, dry, hair-free skin